Background: Histological inflammation correlates with the degree of baseline olfactory dysfunction in patients with chronic rhinosinusitis (CRS); however, factors associated with improvement in olfactory status after endoscopic sinus surgery (ESS) remain elusive. Our purpose was to compare histopathological findings in CRS patients with olfactory loss and evaluate whether inflammatory markers can predict long-term olfactory improvement after ESS.
O lfactory loss is considered a defining symptom of chronic rhinosinusitis (CRS) according to the latest American Academy of Otolaryngology-Head and Neck Surgery clinical practice guideline. 1 An estimated 500,000 surgical procedures are performed each year to address symptoms related to CRS, including olfactory dysfunction. 2 A common question posed by patients with CRS and olfactory loss is the likelihood that endoscopic sinus surgery (ESS) will improve their sense of smell. Substantial evidence exists that supports the efficacy of ESS to improve most sinusitis-specific symptoms including nasal obstruction, facial pressure, and nasal discharge. [3] [4] [5] [6] Despite these findings, improvement in olfaction after ESS has been less consistent and more difficult to predict. [7] [8] [9] [10] Olfactory deficits in the setting of CRS have long been attributed to a conductive mechanism, where mucosal edema or polyps restrict airflow to the olfactory cleft. 7 More recently, the importance of a sensorineural component has been recognized. 11 In this sensorineural mechanism, direct damage to the neuroepithelium from chronic inflammation results in olfactory loss, independent of whether odorant molecules have access to the olfactory mucosa. In a study by Kern, mucosal biopsy specimens were taken both from the sinuses and the olfactory cleft in patients undergoing ESS for CRS. 11 A similar inflammatory infiltrate of lymphocytes, macrophages, and eosinophils was found in both regions of the sinonasal cavity. The extent of mucosal inflammation appeared to correlate with the degree of baseline olfactory dysfunction; however, definitive conclusions could not be made. We have previously published histopathological findings from this cohort of patients with CRS. 12, 13 In these studies, the presence of specific inflammatory markers, viz., eosinophilia, was found to correlate not only with baseline disease severity but also quality-of-life outcomes after ESS. What remains unknown is whether these same histopathological findings correlate with baseline olfactory dysfunction and whether they can be used to predict olfactory outcomes after ESS. The purpose of the present study was to compare histopathological findings in CRS patients with varying levels of olfactory loss and evaluate whether these findings can predict baseline olfactory dysfunction and long-term olfactory improvement after ESS.
METHODS

Study Population
Adult (Ն18 years) subjects with CRS were prospectively enrolled from an academic, tertiary care rhinology practice after electing to undergo ESS. All subjects were diagnosed with CRS according to guidelines established by the Rhinosinusitis Task Force. 14 Inclusion criteria required a failure of medical management, including at least 3 weeks of broad-spectrum or culture-directed antibiotics in addition to a trial of topical nasal steroid therapy. Demographic and comorbidity data were collected by the Principal Investigator during normal intake procedures and included age, gender, nasal polyposis, asthma, acetylsalicylic (ASA) intolerance, allergic rhinitis (confirmed via skinprick testing or modified radioallergic sorbent testing), septal devia-
tion, history of prior sinus surgery, and current smoking. Baseline objective disease severity was assessed using computed tomography (CT) (Lund-Mackay) and endoscopy (Lund-Kennedy) scoring systems. 15, 16 The Institutional Review Board at Oregon Health and Science University provided approval of study protocol and the informed consent process.
Olfactory Assessment
Olfactory function was quantified using the Smell Identification Test (SIT; Sensonics, Inc., Haddon Heights, NJ). The SIT is a validated, forced choice, "scratch and sniff" test using microencapsulated odorant strips (score, 0-40). 17 Patients with preoperative SIT scores of Յ5 were excluded from further analysis because of possible malingering. Subjects were asked to complete the SIT preoperatively and again at postoperative time points during the course of standard follow-up. Patients with Ͼ6 months follow-up were assessed with the longest follow-up point used for outcome analysis.
Histological Evaluation
All subjects were prescribed perioperative medical management for ongoing sinus symptoms and to prepare the mucosa for ESS. This included an oral prednisone taper 7 days before surgery (4 days of 30 mg/day followed by 3 days of 20 mg/day), oral antibiotics, and continued nasal steroid application or allergy therapy when necessary. Sinus mucosal tissue was removed from the ethmoid cavity at the time of surgery. This included the tissue necessary to complete a standard endoscopic ethmoidectomy. Hematoxylin and eosin stains of mucosal tissue were performed as previously reported. 12 Histolog-ical review was performed in a blinded fashion by a single, boardcertified surgical pathologist using a binocular microscope.
Histological analysis was performed with the goal of identifying and quantifying 11 distinct cellular, epithelial, and stromal inflammatory markers ( Table 1 ). The area of densest cellular infiltrate within each sample was used to consistently classify subjects. All cellular markers were recorded as absolute number per high-power field (HPF). Epithelial markers were categorized into determinations of inflammatory severity: goblet cells were quantified as a percentage of epithelial cells within 200-250 m mucosal fragments, basement membrane (BM) thickening was measured in curettage fragments with optimal transverse orientation, and squamous metaplasia was measured using a semiquantitative ordinalization. Likewise, all stromal markers were measured and categorized in a semiquantitative fashion using a similar grading scheme.
Statistical Analysis
Data were collected on standardized clinical research forms and analyzed using SPSS Version 17.0 statistical software (SPSS, Inc., Chicago, IL). Patients were categorized according to SIT scores into normosmic, hyposmic, and anosmic groups based on gender-adjusted normative distributions ( Table 2 ). 18 Differences in demographic factors, clinical characteristics, diagnostic testing, and baseline histological inflammatory markers were assessed across preoperative olfactory categories using the Kuskall-Wallis and chi-square tests where appropriate. All ordinal measures of histological review were collapsed into dichotomous measures because of small and zero cell sizes. Subjects with Ͼ5 eosinophils/HPF were considered to have a positive indication of eosinophilia. 12, 19 Postoperative change in SIT scores across olfactory categories was assessed using the Wilcoxon signed-rank test. Multivariate logistic regression modeling was used to adjust for independent risk factors that might confound postoperative improvement in SIT score. Preliminary models included all individual histological variables as the main exposure variables of interest as well as other cofactors with univariate significance (p Յ 0.25). The main dependent variable of interest was postoperative improvement in SIT score, defined by an absolute postoperative change of Ն4 points (10%). 20 Covariates were introduced into all bivariate models with each histological factor to assess confounding. A covariate resulting in an alteration of the effect estimate for each histological variable by at least 10% was considered a significant confounder. Final models were chosen with manual backward selection in a stepwise fashion. Mean scores and SDs are reported for 
RESULTS
Demographic Data and Baseline Clinical Characteristics
A total of 110 patients had histological samples and preoperative SIT scores available for analysis. One patient was excluded for possible malingering and 8 failed to complete postoperative olfactory evaluations, leaving a final cohort of 101 patients. The final cohort had a mean follow-up of 16.7 Ϯ 6.0 months and included 24 anosmic, 40 hyposmic, and 37 normosmic patients. Baseline demographic and clinical characteristics are shown in Table 3 . Patients with olfactory dysfunction were more likely to be older, of male gender, and have worse CT and endoscopy scores. Nasal polyposis, asthma, aspirin intolerance, and allergic rhinitis were also more common in anosmic patients compared with patients with less severe olfactory impairment.
Baseline Histological Measures
Baseline histological findings are shown in Table 4 . In regard to cellular markers of inflammation, average mucosal eosinophil count was higher in patients with hyposmia and anosmia (p Ͻ 0.001), although each olfactory group displayed a wide range of eosinophil counts. A significantly higher percentage of subjects with anosmia also presented with eosinophil counts of Ͼ5/HPF (p Ͻ 0.001). No differences were found across olfactory categories in regard to absolute counts of mast cells, plasma cells, or macrophages. Lymphocytic cellular markers were present in all ethmoid mucosal samples, with no significant differences between olfactory categories. Neutrophils were not noted in any biopsy samples during histological review. Patients with preoperative anosmia were more likely to have greater severity of BM thickening compared with subjects with hyposmia or normosmia (p ϭ 0.021). No further difference between olfactory groups was seen for any other epithelial or stromal inflammatory markers. When controlling for the presence of polyps, neither eosinophils nor BM thickening continued to be associated with baseline olfactory dysfunction.
Postoperative Change in Olfaction
Mean preoperative and postoperative SIT scores were calculated for each olfactory subgroup (Fig. 1 ). On average, normosmic patients reported similar olfactory function both preoperatively (36.1 Ϯ 1.4; SIT range, 34-39) and postoperatively (34.0 Ϯ 6.5); however, some subjects (n ϭ 6) did report worse postoperative olfactory status (SIT range, 7-38). Hyposmic patients reported similar olfactory SIT scores both preoperatively (28.8 Ϯ 4.2; SIT range, 19-34) and postoperatively (31.2 Ϯ 4.9; SIT range, . Anosmic patients displayed the greatest overall improvement in olfactory function from average preoperative SIT scores (9.6 Ϯ 2.6; SIT range, 6-15) to mean postoperative results (21.8 Ϯ 10.0; SIT range, 7-36; p Ͻ 0.001). In patients with olfactory dysfunction, a total of 35 of 64 patients (54.7%) reported olfactory improvement of Ն4 points postoperative SIT scores, including improvement in 18/24 anosmic (75.0%) and 17/40 hyposmic (42.5%) patients. As expected, none of the normosmic subjects reported postoperative improvement.
Univariate Modeling for Olfactory Improvement
Univariate screening for demographic cofactors found a significantly higher percentage of male subjects reporting improvement in olfactory function (68.6%). Clinical cofactors associated with significant improvement in SIT scores included the presence of polyps (p ϭ 0.006; OR, 3.6; 95% CI, 1.4, 8.0), asthma (p ϭ 0.043; OR, 2.4; 95% CI. 1.0, 5.5), ASA intolerance (p ϭ 0.042; OR, 3.9; 95% CI, 1.0, 14.3), and allergic rhinitis (p ϭ 0.066; OR, 0.4; 95% CI, 0.1, 1.1). In addition to baseline anosmia (p Ͻ 0.001; OR, 10.6; 95% CI, 3.6, 30.9), baseline CT scores (p Ͻ 0.001; OR, 1.1; 95% CI, 1.1, 1.2) and endoscopy scores (p ϭ 0.006; OR, 1.1; 95% CI, 1.0, 1.2) were significantly associated with olfactory improvement.
Univariate screening for independent histological variables found that only subjects with Ͼ5 eosinophils/HPF (p ϭ 0.166; OR, 1.8; 95% CI, 0.8, 4.1) and subepithelial edema (p ϭ 0.155; OR, 2.1; 95% CI, 0.8, 5.9) were marginally associated with improvement in SIT scores. None of the remaining cellular, epithelial, or stromal inflammatory markers was associated with olfactory improvement.
Multivariate Modeling for Olfactory Improvement
To control for potential confounding effects, multivariate modeling was used to adjust for demographic and clinical characteristics found to be significant on univariate analysis. On multivariate analysis, the presence of polyps and allergic rhinitis remained highly associated with olfactory improvement, whereas male gender, asthma, and ASA intolerance were no longer significant. After adjusting for the presence of polyps, mucosal eosinophilia was no longer associated with olfactory improvement (p ϭ 0.638). Similarly, subepithelial edema was no longer predictive of olfactory improvement after controlling for polyp status (p ϭ 0.812).
DISCUSSION
This study sought to determine whether specific histopathological findings are present in CRS patients with varying degrees of olfactory dysfunction and whether these findings could be used as clinically relevant predictors of olfactory function after surgery. Mucosal eosinophilia and BM thickening were more commonly seen in patients with severe olfactory dysfunction. This finding was similar to Kern's study, which found more intense inflammation in patients with olfactory dysfunction. 11 However, when controlling for the presence of polyps, neither eosinophils nor BM thickening were independent predictors of baseline olfactory dysfunction. In fact, 22 (92%) anosmic patients presented with nasal polyposis, which increases the likelihood of perfect confounding by polyp status rather than a true association between histopathology and olfactory dysfunction. Given that histological findings did not correlate with baseline olfactory dysfunction, it was not surprising that histology also failed to predict olfactory improvement after surgery.
The concept of conductive and sensorineural mechanisms of olfactory loss in CRS certainly seems probable based on available evidence. 21 However, the relative contribution of each mechanism to olfactory loss is unknown. Furthermore, the mechanism by which available treatments, either surgical or medical, improve olfactory function is not clearly established. For example, patients with nasal polyposis and anosmia will sometimes regain olfactory function after prolonged courses of oral steroids. This outcome may be caused by shrinkage of polyps with improved access of odorants to the olfactory cleft, resolution of direct mucosal inflammation in the olfactory cleft, or both. 21 Sinus surgery in patients with nasal polyps serves to physically remove polyps and improve airflow throughout the sinonasal cavity. However, surgery also likely decreases the overall state of mucosal inflammation by clearing chronic infection and promoting mucous drainage. Very few studies have sought to directly biopsy the olfactory mucosa in disease states such as CRS. This is not surprising given the difficulty of safely accessing the olfactory cleft and theoretical risks of permanent smell loss. It is seemingly unlikely that elucidation of the precise mechanism of baseline olfactory loss will be possible without further attempts at direct biopsy both before and after available treatments.
In this cohort, 75% of anosmic patients showed improvement in olfactory function after ESS. Despite this improvement, most patients remained in the severely hyposmic range. It remains unknown why these patients were left with significant olfactory dysfunction, given that ESS serves to physically remove obstructing polyps and diminish the overall inflammatory state of the sinonasal mucosa. One possibility is that a certain amount of olfactory loss is permanent. Some have proposed that pathological insults such as sinusitis may trigger uncompensated increases in olfactory cell death with a net loss of olfactory sensory neurons over time. [21] [22] [23] Additionally, it is known that olfactory function decreases with age, likely because of the cu- mulative effects of environmental exposure with replacement of olfactory mucosa by respiratory epithelium. 24 If these processes are indeed occurring, then the genetic susceptibility of the host may be as relevant as the specific nature or intensity of the histopathological insult.
There are several important limitations of this study that increase the chance of a type II error (no association found between histological inflammation and olfactory improvement when, in fact, one exists). Patients in this limited cohort were on a short course of oral steroids before intraoperative ethmoid mucosal sampling. We did not control for steroid use at the time of surgery, which has the theoretical potential to decrease the degree of inflammatory markers seen in mucosal specimens. Steroids may effectively reduce the presence of histological markers and confound (dilute) the relationship between histological markers and olfactory improvement. Second, mucosal specimens were taken from the ethmoid cavity as opposed to the olfactory mucosa. Patients with CRS have sinus mucosal inflammation by definition; however, it is not necessarily true that all patients with CRS also have inflammation of the olfactory mucosa. In the study by Kern et al., a similar inflammatory infiltrate was present in the sinus mucosa and olfactory mucosa; however, the degree of inflammation was generally greater in the sinus mucosa compared with the olfactory mucosa. 11 If the severity of olfactory inflammation is truly less than sinus mucosal inflammation, the prevalence of inflammatory markers measured in this study may have been insufficient to show a true association as measured.
CONCLUSION
Olfactory dysfunction was a common finding in patients with CRS. Patients with severe olfactory dysfunction were more likely to have mucosal eosinophilia and BM thickening on ethmoid histopathological examination compared with those with normal olfaction. Despite these findings, the presence of specific histological inflammatory findings did not help predict olfactory improvement after surgery. Olfactory loss in the setting of CRS remains a troublesome problem and further study is warranted to understand olfactory outcomes after sinus surgery. 
